Creative Biosciences
OverviewSuggest Edit
Creative Biosciences (广州市康立明生物科技有限责任) is a biotech company that is engaged in research, development, and manufacture of diagnostic tools for tumors detection. It produces COLOSAFE, a stool DNA methylation testing kit for auxiliary diagnosis of colorectal cancer.
| Type | Private | |
| Founded | 2015 | |
| HQ | Guangzhou, CN | Map |
| Website | kangliming.com |
Latest Updates
| Cybersecurity rating | A | More |
Creative Biosciences Financials and Metrics
Summary Metrics
Founding Date | 2015 |
Creative Biosciences total Funding | $144 m |
Creative Biosciences latest funding size | $88 m |
Time since last funding | a year ago |
Creative Biosciences investors | CDH Investments, IDG Capital, CD Capital, Tsing Song Capital |
Creative Biosciences's latest funding round in September 2020 was reported to be $88 m. In total, Creative Biosciences has raised $144 m
Creative Biosciences Cybersecurity Score
Creative Biosciences Online and Social Media Presence
Creative Biosciences's Trends
Creative Biosciences News and Updates
September 27, 2020
Chinese biotech firm Creative Biosciences raises $88m from IDG, CDH, others
Healthcare-focused private equity firm Tsing Song Capital was the lead investor.
The post Chinese biotech firm Creative Biosciences raises $88m from IDG, CDH, others appeared first on DealStreetAsia.
Creative Biosciences Frequently Asked Questions
When was Creative Biosciences founded?
Creative Biosciences was founded in 2015.
Who are Creative Biosciences competitors?
Competitors of Creative Biosciences include Amoy Diagnostics, Check-Cap and Biomedica Molecular Medicine.
Where are Creative Biosciences offices?
Creative Biosciences has an office in Guangzhou.
How many offices does Creative Biosciences have?
Creative Biosciences has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies